# Forensic Dossier: Study Forensics: APJ agonist as pharmacological exercise mimetic

**Run ID:** `mechfix_study-forensics-030_Claude_Opus_965960`  
**Task:** study-forensics-030 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T16:42:54.200817+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** preclinical_to_therapeutic_leap  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **70.5/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 3
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.6/6 | 4.5/6 | 4.8/8 | 8.0/8 | 0.0/10 | 10.0/10 | **70.5/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control, correlation_as_causation

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 5

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "mechanism_vs_evidence"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "mechanism_vs_evidence"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "mechanism_vs_evidence"


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "mechanism_vs_evidence"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 5
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[1]`: "Noted the specific outcomes measured were mouse-specific (glycemic control, HbA1c, weight loss, cardiac hypertrophy in m"
    _Most informative reasoning step_
  - Note: 5 reasoning steps
  - Note: Low step utility: 0/5 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[2]`: "The company is making forward-looking statements about human therapeutic potential"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[0]`: "The exact phrasing of the company's claims beyond what's summarized"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[0]`: "The exact phrasing of the company's claims beyond what's summarized"
    _Listed but never addressed in reasoning_
  - Note: 3 uncertainties (3 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "Could be overclaim if the human therapeutic claims were more definitive rather than forward-looking"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 genuinely diverse alternatives

**Self Monitoring Quality:** 4.8/8
  - (+) `self_check[3]`: "The company's preparation for human trials shows they are making this bridge despite lack of human evidence"
    _Most substantive self-verification step_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 4 arithmetic, 0 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.71, 271 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "mechanism_vs_evidence"
  - _Impacts: support_strength, structural_reasoning_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'The exact phrasing of the company's claims beyond what's sum...' is listed but not addressed
  - `uncertainties[0]`: "The exact phrasing of the company's claims beyond what's summarized"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/11 content words)
  - `key_claims[0]`: "Clear evidence-tier mismatch: mouse studies being used to support human therapeutic development plan"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/8 content words)
  - `key_claims[1]`: "The phrase 'pharmacological exercise mimetic' implies human therapeutic application"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (1/10 content words)
  - `key_claims[2]`: "Preparing for human trials indicates therapeutic intent beyond the current evidence base"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 1 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[0]`: "The exact phrasing of the company's claims beyond what's summarized"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Could be classified as solid if the text only reported mouse findings without human implications"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Could be overclaim if the human therapeutic claims were more definitive rather than forward-looking"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 17483ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.9

**Assumptions:**
- The study was conducted entirely in mouse models
- No human data is presented
- The company is making forward-looking statements about human therapeutic potential
- The preclinical results are being used to justify human trial preparation

**Reasoning Steps:**
1. Identified that all evidence comes from mouse models (obese/diabetic mice, heart-failure model mice)
2. Noted the specific outcomes measured were mouse-specific (glycemic control, HbA1c, weight loss, cardiac hypertrophy in mice)
3. Recognized the conclusion tier jumps to human therapeutic potential ('pharmacological exercise mimetic', 'preparing to translate the approach into human trials')
4. Evaluated whether the bridge from mouse to human is supported by evidence - it is not, only by future intent
5. The text implies this could work as a human therapy despite having only animal evidence

**Key Claims:**
- Clear evidence-tier mismatch: mouse studies being used to support human therapeutic development plans
- The phrase 'pharmacological exercise mimetic' implies human therapeutic application
- Preparing for human trials indicates therapeutic intent beyond the current evidence base

**Alternative Hypotheses:**
- Could be classified as solid if the text only reported mouse findings without human implications
- Could be overclaim if the human therapeutic claims were more definitive rather than forward-looking

**Uncertainties:**
- The exact phrasing of the company's claims beyond what's summarized
- Whether any human safety or PK/PD data exists but wasn't mentioned
- The strength of the preclinical evidence itself

**Self-Verification:**
- Confirmed this is not overclaim because the company acknowledges these are preclinical results
- Verified this is not correlation vs causation as the mouse studies appear to be intervention studies
- The issue is specifically the leap from successful mouse studies to implied human therapeutic potential
- The company's preparation for human trials shows they are making this bridge despite lack of human evidence

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 4.8/8 `######....`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **70.5/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.8/6)
- Uncertainty Handling: Claude Opus (3.6/6)
- Alternative Hypothesis Quality: Claude Opus (4.5/6)
- Self Monitoring Quality: Claude Opus (4.8/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 17.5s | 70.5/100 | 4.0 |

Failure modes observed: decorative_uncertainty, unsupported_conclusion, unsupported_intermediate_step.
